• A
• A
• A

SNCC’s research program gives patients local access to national cancer research, so patients can benefit from national research without having to travel elsewhere.

Joining a clinical trial is always voluntary. Most participants are seeking a better treatment option and also wish to take part in the fight against cancer.

Our research staff carefully selects promising studies to offer locally. We work with study sponsors to ensure that informed consent processes are followed properly and monitor the progress of our research participants. We also look into specific studies on behalf of patients or physicians who wish to learn more about a trial opportunity.

The research department supports patients and the local medical community in many ways.

• We evaluate hundreds of trials offered by drug companies and research institutions.
• We work actively with drug companies to bring promising new treatments to Lincoln.
• We partner with the Cancer Resource Center of Lincoln to provide access to public trials from National Institutes of Health regional research groups.
• We affiliate with Eppley Cancer Research Institute at the University of Nebraska Medical Center to provide local access to UNMC clinical trials.
• We work with local physicians to inform them about clinical trials that may be of interest to their patients.
• We educate and follow up with patients who wish to participate in research.

In all cases we provide complete information to patients and fully explain a trial, and we leave the decision of whether or not to participate to patients and their physicians. To learn more about research, visit the Clinical Trials section of this website.

Recently, SNCC has been the driving force behind the Midwest Personalized Oncology Program (MPOP). This federally funded project is being pioneered in Lincoln, Nebraska, and is the first of its kind in the United States. MPOP is a collaboration of local physicians and patients who are helping national researchers explore the genetic basis of cancer.

The idea is that patients who undergo a cancer surgery or biopsy will donate a small sample of tumor tissue to researchers studying cancer genes. This leftover material would normally be discarded. A sample of tissue as small as a quarter provides valuable information for scientists on the frontiers of oncology. Participating in MPOP does not change a patient’s standard of care. Already, many Lincoln patients and doctors have joined this important effort. To learn more, please visit www.save-your-tumor.com.

Patient Education:

SNCC’s Research Department helps patients assess all their care options. We work closely with your physician to identify the very best opportunities for your treatment. We walk patients through the process of trial participation, and we provide follow up information on trials as needed. The Research Department also coordinates with SNCC medical providers to make sure your personal contribution to science is a successful and gratifying experience.

Staff Education:

Additionally, our research program hosts regular seminars to ensure our staff is continually updated on current research findings, in the literature, as well as results of current clinical trials. We believe this improves the overall care to our patients.